Target intelligence / Profile preview

Proton channel OTOP3 (OTOP3)

Target
OTOP3
Molecular classification
Ion channel (specifically, proton-selective channel), Transmembrane protein, Otopetrin family
01

Overview

Proton channel OTOP3 (OTOP3) is a transmembrane ion channel belonging to the otopetrin family, responsible for highly selective transport of protons (hydrogen ions) across the cell membrane. It consists of a homodimeric structure, where each subunit has 12 transmembrane helices that form N-terminal and C-terminal domains, both likely contributing to proton conduction. OTOP3 is mainly expressed in the duodenum and small intestine, with critical roles in the formation and function of otoliths/otoconia in the inner ear—structures that are essential for sensing gravity and linear acceleration. Mutations or dysfunction in OTOP3 may contribute to vestibular system disorders such as vertigo due to disruption of these structures. The precise cellular and molecular functions, as well as potential for therapeutic targeting, remain under investigation, and no specific drugs are currently approved for or known to target OTOP3 directly.

Other names
Otopetrin-3OTOP3otopetrin 3proton channel OTOP3
02

Mechanism of action

If drugs were developed, likely mechanisms would be modulation or inhibition/activation of proton transport activity in the channel. For related channels, zinc can inhibit activity by blocking proton currents.

03

Biological functions

Proton transport across cell membranes (regulates intracellular and extracellular pH)Essential for the normal formation of otoliths/otoconia in the inner ear, which are critical for balance and gravity sensationMay support regulation of biochemical and developmental processes via pH changesInvolved in vestibular system development/functionNucleic acid binding activity reported
04

Disease associations

Vertigo and loss of balance (linked to degeneration or displacement of otoconia)Vestibular disorders (via otoconia/otolith formation)No established links to cancer, inflammation, neurodegenerative diseases, cardiovascular disease, or infection
05

Safety considerations

Not documented. Theoretical concerns might involve disruption of vestibular function and balance if the channel is inhibited.
06

Interacting drugs

No specific drugs identified that target OTOP3. Zinc ions (Zn²⁺) can inhibit related proton channels in vitro, but are not established as therapeutics.
07

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Proton channel OTOP3 (OTOP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proton channel OTOP3 (OTOP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call